An immunomodulatory peptide derived from the thymus gland, approved in several countries for hepatitis B/C and studied for immune enhancement in cancer and infectious diseases.
The Cochrane database of systematic reviews|2019|Day P, Duggal M, Nazzal H
BACKGROUND: Traumatic dental injuries are common. One of the most severe injuries is when a permanent tooth is knocked completely out of the mouth (avulsed). In most circumstances the tooth should be replanted as quickly as possible. There is uncerta…
ReviewMeta-Analysis
PMID: 30720860
International immunopharmacology|2019|Shen X et al.
Thymosin alpha 1 (Tα1) is an immunomodulatory polypeptide secreted from the thymus. Tα1 has a wide range of biological functions, such as immunomodulation and endocrine regulation. Tα1 also displays antiviral and antitumor activities. Tα1 has been su…
Animal Study
PMID: 31220695
Cellular and molecular biology (Noisy-le-Grand, France)|2019|Ma Y et al.
Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) was positively correlated with serological hepatitis B surface antigen (HBsAg) levels in hepatitis B e antigen (HBeAg) positive chronic hepatitis B (CHB) patients. We evaluated whether T…
Randomized Controlled Trial
PMID: 30860474
Transplantation proceedings|2019|Peng H et al.
Mucormycosis is an uncommonly encountered fungal infection in solid-organ transplantation, occurring most often gastrointestinally. The most common and fatal infectious disease is cytomegalovirus (CMV) pneumonia, which may result in acute respiratory…
ReviewCase Report
PMID: 30879589
Journal of pharmaceutical and biomedical analysis|2019|Wang T et al.
Thymosin α1 (Thymalfasin, Tα1) is a naturally occurring polypeptide widely used as an immune system enhancer for the treatment of HIV/AIDS, hepatitis B and C, and cancer. Recombinant human Tα1 (rh-Tα1) lacking N-terminal acetylation (NTA) displays si…
Animal Study
PMID: 30903925
JCI insight|2019|Tomati V et al.
PMID: 30944255
Bioorganic chemistry|2019|Kharazmi-Khorassani J, Asoodeh A, Tanzadehpanah H
In this research, the antioxidant property of thymosin alpha-1 (Thα1) peptide was investigated through various antioxidant methods. Thα1 showed 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity (IC = 20 µM) and its 2,2-azino-bis (3-eth…
Animal StudyIn Vitro
PMID: 30974297
Environmental toxicology|2019|Kharazmi-Khorassani J, Asoodeh A
This research was conducted to investigate the biochemical effects of thymosin alpha-1 using human lung cancer cells (A549). The A549 cells were treated with different concentrations of Thα1 for 24 h and the growth, inhibition of cells was determined…
In Vitro
PMID: 31067016
Heliyon|2019|Karachaliou C et al.
Prothymosin alpha (ProTα) is a highly conserved polypeptide (109 amino acids in humans) with diagnostic and therapeutic potential; ProTα exerts intra- and extra-cellular biological functions associated with cell proliferation, apoptosis and immune re…
In Vitro
PMID: 31720448
Neuroscience bulletin|2019|Xu Y et al.
Activation of inflammatory responses regulates the transmission of pain pathways through an integrated network in the peripheral and central nervous systems. The immunopotentiator thymosin alpha-1 (Tα1) has recently been reported to have anti-inflamm…
PMID: 30790216
Frontiers in immunology|2019|Ahmad B et al.
This study pertains to the new approach for the development of hybrid peptide LL-37Tα1 and its biomedical applications. A linear cationic hybrid peptide, LL-37Tα1 was derived from two parental peptides (LL-37 and Tα1) recognized as potent anti-endoto…
Animal Study
PMID: 31258535
Annals of clinical and laboratory science|2019|Xiong W et al.
OBJECTIVE: This study aims to investigate the changes in CD3, CD4and CD8expression in cells in peripheral blood of silicosis patients, and observe the immunoregulatory effect of thymalfasin. METHODS: A total of 80 silicosis patients were enrolled in…
PMID: 31308037
Scientific reports|2019|Armirotti A et al.
Deletion of phenylalanine 508 (F508del) in the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel is the most frequent mutation causing cystic fibrosis (CF). F508del-CFTR is misfolded and prematurely degraded. Recently thymosin…
PMID: 31311979
Frontiers in immunology|2019|Zhang L et al.
Intestinal inflammatory disorders, such as inflammatory bowel disease (IBD), are associated with increased pro-inflammatory cytokine secretion in the intestines. Furthermore, intestinal inflammation increases the risk of enteric cancer, which is a co…
Animal Study
PMID: 31447849
Data in brief|2018|Wang F et al.
The data presented in this article are related to the research article entitled "Immunomodulatory and Enhanced Antitumor Activity of a Modified Thymosin α1 in Melanoma and Lung Cancer" (Wang et al., 2018). Tα1 has been evaluated as effective in cance…
Animal Study
PMID: 30109250
Scientific reports|2018|Wang F et al.
Thymosin alpha 1 (Tα1) is a biological response modifier that has been introduced into markets for treating several diseases. Given the short serum half-life of Tα1 and the rapid development of Fc fusion proteins, we used genetic engineering method t…
Animal Study
PMID: 30120362
Oncology letters|2018|Zhou L et al.
Although liver transplantation (LT) lengthens the survival time of patients with hepatocellular carcinoma (HCC), LT patients exhibit a high recurrence rate; particularly those that had advanced HCC associated with the tumor biological characteristics…
PMID: 30214575
Oncoimmunology|2018|Du D et al.
This study investigated the anti-tumor effects of stereotactic body radiation therapy (SBRT) with thymosin alpha-1 (Tα1) in heavily pretreated, metastatic esophageal squamous cell carcinoma (mESCC) patients. Thirty-one patients with at least 2 metast…
PMID: 30221039
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie|2018|Shen X et al.
Thymosin alpha1 (Tα1) is a multifunctional polypeptide involved in immunoregulation, which universally exists in various organs. The clinical application, however, is limited because of its short half-life. The Fc domain of human IgG has functional p…
Animal Study
PMID: 30243095
Frontiers in immunology|2018|Freeley S et al.
Autocrine activation of the complement receptors C3aR and CD46 by complement activation components C3a and C3b produced through C3 cleavage by the protease cathepsin L (CTSL) during T cell stimulation is a requirement for IFN-γ production and Th1 ind…
PMID: 30405635